Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476).

Published in:

International Journal of Cancer, 2022, v. 151, n. 3, p. 422, doi. 10.1002/ijc.34018

By:

• James, Nicholas D.;
• Clarke, Noel W.;
• Cook, Adrian;
• Ali, Adnan;
• Hoyle, Alex P.;
• Attard, Gerhardt;
• Brawley, Christopher D.;
• Chowdhury, Simon;
• Cross, William R.;
• Dearnaley, David P.;
• de Bono, Johann S.;
• Diaz‐Montana, Carlos;
• Gilbert, Duncan;
• Gillessen, Silke;
• Gilson, Clare;
• Jones, Rob J.;
• Langley, Ruth E.;
• Malik, Zafar I.;
• Matheson, David J.;
• Millman, Robin

Publication type:

Article